Zambia Medicines Regulatory Authority · Zambia
DEA-ZM-2026-63941389
Tier 1 · Regulator-publishedClass IIRecallStatus · active
- Issuing authority
- Zambia Medicines Regulatory Authority (ZAMRA)
- Authority reference
- Not stated by the issuing authority
- Date issued
- 07 Jan 2026Format ambiguous in the source; resolved to 2026-01-07 by the table's chronological order.
- Recorded by us
- 2026-09-06 18:40:27 UTC
- Product
- Cloxispa-250 Cloxacillin Capsules BP 250mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Sparsh Bio-Tech Pvt. Ltd., India
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- CC315
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Class II as issued
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Out of specification — assay
- Product type
- Medicine
- ATC code
- Not stated by the issuing authority
- Affected markets
- Zambia — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- OOS-AssayOriginal language: en
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 39
Where this record came from, and what is held to show it.
- Primary source
- https://www.zamra.co.zm/recalls/
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- c54b9a0d9cd089bd9eaa4379b4693a27da3c1e125cac125a556fba6a47e049b3SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-10-03 10:37:01 UTC
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-EG-2026-0176 | 05 Sept 2026 | EG | vilaphoria 40 mg film coated tablet Rameda | 254227 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0175 | Aug 2026 | EG | Appavisc HVPFS | AVH-051-E | Recall | Class I | Tier 1 · Regulator-published |
| DEA-ZM-2026-40339800 | 13 Feb 2026 | ZM | Sabulin (Salbutamol Tablets BP 4mg) Dawa Ltd , Kenya | 2310025 | Recall | Class I | Tier 1 · Regulator-published |
| DEA-KE-2025-0035 | 14 Nov 2025 | KE | Cardoz 12.5 Ipca Laboratories Limited, India | GBC013001 | Recall | Unclassified | Tier 1 · Regulator-published |
| DEA-ZM-0000-42714800 | undated | ZM | KLOXY 250 CLOXACILLIN 250MG CAPSULES LABORATORY AND ALLIED LIMITED KENYA | 86435 | Recall | Class I | Tier 1 · Regulator-published |
Cite this record
Drug Eye Africa (2026). DEA-ZM-2026-63941389: Cloxispa-250 Cloxacillin Capsules BP 250mg — Recall, Zambia Medicines Regulatory Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/zm/2026/dea-zm-2026-63941389Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.